Commodore Capital LP 13D and 13G filings for Inhibikase Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:11 pm Purchase | 2026-03-31 | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | Commodore Capital LP | 14,054,940 9.900% | 7,247,433 (+106.46%) | Filing |
| 2024-10-17 4:05 pm Purchase | 2024-10-09 | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | Commodore Capital LP | 6,807,507 9.990% | 6,807,507 (New Position) | Filing |